GlaxoSmithKline PLC Director/PDMR Shareholding (6713L)
April 20 2018 - 9:15AM
UK Regulatory
TIDMGSK
RNS Number : 6713L
GlaxoSmithKline PLC
20 April 2018
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
=== =========================================================================
a) Name Mr N Hirons
=== ======================== ===============================================
b) Position/status SVP, Global Ethics & Compliance
=== ======================== ===============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================================
a) Description of GlaxoSmithKline plc American Depositary
the financial Shares ('ADSs')
instrument ISIN: US37733W1053
=== ======================== ===============================================
b) Nature of the Acquisition of ADSs following the re-investment
transaction of dividends paid to shareholders on 12
April 2018.
=== ======================== ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
$40.534 23.721
--------- ----------
=== ======================== ===============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===============================================
e) Date of the transaction 2018-04-17
=== ======================== ===============================================
f) Place of the New York Stock Exchange (XNYS)
transaction
=== ======================== ===============================================
1. Details of PDMR/person closely associated with them
('PCA')
=== =========================================================================
a) Name Mr B McNamara
=== ======================== ===============================================
b) Position/status CEO, Consumer Healthcare
=== ======================== ===============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ======================== ===============================================
b) Nature of the Acquisition of ADSs following the re-investment
transaction of dividends paid to shareholders on 12
April 2018.
=== ======================== ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
$40.534 535.096
--------- ----------
=== ======================== ===============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===============================================
e) Date of the transaction 2018-04-17
=== ======================== ===============================================
f) Place of the New York Stock Exchange (XNYS)
transaction
=== ======================== ===============================================
1. Details of PDMR/person closely associated with them
('PCA')
=== =========================================================================
a) Name Mr D E Troy
=== ======================== ===============================================
b) Position/status SVP & General Counsel
=== ======================== ===============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ======================== ===============================================
b) Nature of the Acquisition of ADSs following the re-investment
transaction of dividends paid to shareholders on 12
April 2018.
=== ======================== ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
$40.534 2,863.339
--------- ----------
=== ======================== ===============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===============================================
e) Date of the transaction 2018-04-17
=== ======================== ===============================================
f) Place of the New York Stock Exchange (XNYS)
transaction
=== ======================== ===============================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHZBLFLVZFBBBX
(END) Dow Jones Newswires
April 20, 2018 10:15 ET (14:15 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024
